Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension
暂无分享,去创建一个
P. Khatri | H. Hedlin | W. Robinson | A. Sweatt | A. Hsi | F. Haddad | R. Condliffe | M. Nicolls | M. Rabinovitch | V. Balasubramanian | A. Lawrie | R. Zamanian | L. Blum | P. Hickey | Andrew C. Hsi
[1] S. Bakker,et al. Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia. , 2020, Blood advances.
[2] M. Kool,et al. Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective , 2020, Journal of clinical medicine.
[3] J. Loscalzo,et al. The application of big data to cardiovascular disease: paths to precision medicine. , 2020, The Journal of clinical investigation.
[4] Declan P. O'Regan,et al. Artificial Intelligence for Cardiac Imaging-Genetics Research , 2020, Frontiers in Cardiovascular Medicine.
[5] Joseph Loscalzo,et al. Emerging Role of Precision Medicine in Cardiovascular Disease. , 2018, Circulation research.
[6] W. Chung,et al. PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics. , 2017, Circulation research.
[7] M. Humbert,et al. Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study , 2017, The Lancet. Respiratory medicine.
[8] R. Dweik,et al. Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass. , 2017, American journal of respiratory and critical care medicine.
[9] Sanjiv J. Shah,et al. Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. , 2017, American journal of respiratory and critical care medicine.
[10] N. Voelkel,et al. The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension , 2017, American journal of respiratory and critical care medicine.
[11] P. Corris,et al. Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension , 2017, Circulation.
[12] Zhongming Zhao,et al. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. , 2016, American journal of respiratory and critical care medicine.
[13] Edmond J. Breen,et al. The Statistical Value of Raw Fluorescence Signal in Luminex xMAP Based Multiplex Immunoassays , 2016, Scientific Reports.
[14] A. Torbicki,et al. Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. , 2015, American journal of respiratory and critical care medicine.
[15] M. Humbert,et al. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex. , 2015, American journal of respiratory and critical care medicine.
[16] N. Morrell,et al. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension. , 2015, American journal of respiratory and critical care medicine.
[17] S. Rich,et al. Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension , 2015, Circulation.
[18] N. Voelkel,et al. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox. , 2014, American journal of respiratory cell and molecular biology.
[19] George Michailidis,et al. Critical limitations of consensus clustering in class discovery , 2014, Scientific Reports.
[20] M. Humbert,et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. , 2014, Circulation research.
[21] M. Humbert,et al. An official American Thoracic Society Statement: pulmonary hypertension phenotypes. , 2014, American journal of respiratory and critical care medicine.
[22] M. Humbert,et al. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension , 2013, European Respiratory Journal.
[23] Horst Olschewski,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[24] Hong Wang,et al. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats. , 2013, Vascular pharmacology.
[25] M. Eghbali,et al. Estrogen paradox in pulmonary hypertension: current controversies and future perspectives. , 2012, American journal of respiratory and critical care medicine.
[26] B. Dahal,et al. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[27] S. Cross,et al. Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension , 2012, The Journal of experimental medicine.
[28] Des C. Jones,et al. Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension , 2012, Circulation.
[29] S. Groshong,et al. Modern age pathology of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[30] M. Fishbein,et al. Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[31] Verena D. Schmittmann,et al. Qgraph: Network visualizations of relationships in psychometric data , 2012 .
[32] C. Blaisdell,et al. National Heart, Lung, and Blood Institute Workshop: Improving Outcomes for Pulmonary Vascular Disease , 2012, Circulation.
[33] M. Humbert,et al. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension , 2012, European Respiratory Journal.
[34] Marc A Suchard,et al. Modeling Protein Expression and Protein Signaling Pathways , 2012, Journal of the American Statistical Association.
[35] C. Long,et al. Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension , 2011, Circulation research.
[36] M. S. Mcmurtry,et al. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension , 2011, Journal of Molecular Medicine.
[37] Fabian J. Theis,et al. Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data , 2011, BMC Systems Biology.
[38] R. Trembath,et al. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.
[39] John Skvoretz,et al. Node centrality in weighted networks: Generalizing degree and shortest paths , 2010, Soc. Networks.
[40] Matthew D. Wilkerson,et al. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..
[41] E. Mark,et al. Interleukin-6 Overexpression Induces Pulmonary Hypertension , 2009, Circulation research.
[42] R. Tibshirani,et al. Sparse inverse covariance estimation with the graphical lasso. , 2008, Biostatistics.
[43] David Evans,et al. Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension. , 2008, The American journal of pathology.
[44] M. Humbert,et al. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. , 2007, American journal of respiratory and critical care medicine.
[45] KazuyukiShimada,et al. Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats , 2007 .
[46] U. Ikeda,et al. Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats , 2007, Circulation research.
[47] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[48] W. Seeger,et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. , 2005, The Journal of clinical investigation.
[49] Thomas G. Schulze,et al. Defining the Phenotype in Human Genetic Studies: Forward Genetics and Reverse Phenotyping , 2005, Human Heredity.
[50] Alberto de la Fuente,et al. Discovery of meaningful associations in genomic data using partial correlation coefficients , 2004, Bioinform..
[51] Jill P. Mesirov,et al. Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data , 2003, Machine Learning.
[52] H. Makita,et al. Effects of IL‐1β, TNF‐α, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells , 2003, Respirology.
[53] M. Humbert,et al. Chemokine RANTES in severe pulmonary arterial hypertension. , 2002, American journal of respiratory and critical care medicine.
[54] N. Voelkel,et al. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. , 1994, American journal of respiratory cell and molecular biology.
[55] Edward M. Reingold,et al. Graph drawing by force‐directed placement , 1991, Softw. Pract. Exp..